Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX8KIR
|
||||
| Drug Name |
[3-(5-Fluoro-1H-indol-2-yl)-propyl]-(2-phenoxy-ethyl)-amine
|
||||
| Synonyms |
CHEMBL2112644
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H21FN2O
|
||||
| Canonical SMILES |
Fc1ccc2[nH]cc(CCCNCCOc3ccccc3)c2c1
|
||||
| InChI |
InChI=1S/C19H21FN2O/c20-16-8-9-19-18(13-16)15(14-22-19)5-4-10-21-11-12-23-17-6-2-1-3-7-17/h1-3,6-9,13-14,21-22H,4-5,10-12H2
|
||||
| InChIKey |
SBFWLGINQFNKPW-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.